Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 26 studies | 34% ± 18% | |
macrophage | 19 studies | 36% ± 19% | |
classical monocyte | 19 studies | 27% ± 13% | |
oligodendrocyte precursor cell | 12 studies | 37% ± 17% | |
microglial cell | 11 studies | 32% ± 14% | |
myeloid cell | 11 studies | 32% ± 16% | |
astrocyte | 11 studies | 29% ± 14% | |
oligodendrocyte | 11 studies | 35% ± 13% | |
monocyte | 10 studies | 33% ± 14% | |
glutamatergic neuron | 10 studies | 44% ± 26% | |
adipocyte | 9 studies | 47% ± 11% | |
fibroblast | 9 studies | 30% ± 11% | |
GABAergic neuron | 8 studies | 39% ± 22% | |
epithelial cell | 7 studies | 38% ± 20% | |
dendritic cell | 7 studies | 28% ± 10% | |
type I pneumocyte | 6 studies | 27% ± 10% | |
non-classical monocyte | 6 studies | 28% ± 11% | |
neuron | 6 studies | 37% ± 19% | |
pericyte | 6 studies | 25% ± 7% | |
interneuron | 6 studies | 39% ± 24% | |
endothelial cell of lymphatic vessel | 5 studies | 25% ± 9% | |
basal cell | 5 studies | 31% ± 23% | |
ciliated cell | 5 studies | 23% ± 6% | |
club cell | 5 studies | 23% ± 9% | |
alveolar macrophage | 5 studies | 41% ± 18% | |
type II pneumocyte | 5 studies | 24% ± 7% | |
mononuclear phagocyte | 4 studies | 34% ± 19% | |
Mueller cell | 4 studies | 33% ± 15% | |
smooth muscle cell | 4 studies | 21% ± 2% | |
natural killer cell | 3 studies | 18% ± 1% | |
hematopoietic precursor cell | 3 studies | 18% ± 3% | |
GABAergic interneuron | 3 studies | 24% ± 4% | |
amacrine cell | 3 studies | 22% ± 5% | |
retinal ganglion cell | 3 studies | 33% ± 12% | |
endothelial cell of artery | 3 studies | 23% ± 5% | |
vein endothelial cell | 3 studies | 24% ± 11% | |
lymphocyte | 3 studies | 25% ± 8% | |
GABAergic amacrine cell | 3 studies | 29% ± 9% | |
retinal rod cell | 3 studies | 18% ± 2% | |
hepatocyte | 3 studies | 37% ± 28% | |
B cell | 3 studies | 23% ± 6% | |
abnormal cell | 3 studies | 33% ± 14% | |
neutrophil | 3 studies | 30% ± 13% | |
T cell | 3 studies | 21% ± 2% | |
transit amplifying cell | 3 studies | 40% ± 31% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3688.15 | 1445 / 1445 | 100% | 46.32 | 183 / 183 |
lung | 100% | 6725.39 | 578 / 578 | 100% | 34.79 | 1155 / 1155 |
stomach | 100% | 3279.25 | 359 / 359 | 100% | 33.69 | 286 / 286 |
breast | 100% | 6620.48 | 459 / 459 | 100% | 32.54 | 1116 / 1118 |
brain | 100% | 3689.11 | 2637 / 2642 | 100% | 37.08 | 705 / 705 |
intestine | 100% | 4047.11 | 966 / 966 | 100% | 31.21 | 526 / 527 |
uterus | 100% | 3503.74 | 170 / 170 | 100% | 26.95 | 457 / 459 |
ovary | 100% | 3465.13 | 180 / 180 | 100% | 24.48 | 428 / 430 |
thymus | 100% | 3655.89 | 652 / 653 | 99% | 23.00 | 601 / 605 |
prostate | 100% | 2985.78 | 244 / 245 | 99% | 20.21 | 499 / 502 |
kidney | 100% | 3565.31 | 89 / 89 | 99% | 26.43 | 891 / 901 |
bladder | 100% | 4228.52 | 21 / 21 | 98% | 25.11 | 496 / 504 |
skin | 100% | 4779.18 | 1809 / 1809 | 98% | 29.85 | 462 / 472 |
pancreas | 96% | 2224.98 | 316 / 328 | 99% | 27.74 | 176 / 178 |
adrenal gland | 100% | 4497.56 | 258 / 258 | 95% | 17.89 | 219 / 230 |
liver | 97% | 2003.15 | 219 / 226 | 97% | 16.26 | 393 / 406 |
adipose | 100% | 8230.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.90 | 29 / 29 |
spleen | 100% | 5026.79 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.04 | 1 / 1 |
blood vessel | 100% | 4206.13 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2986.57 | 801 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 10508.77 | 925 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 2814.93 | 833 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 13.60 | 72 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006406 | Biological process | mRNA export from nucleus |
GO_0045109 | Biological process | intermediate filament organization |
GO_0001675 | Biological process | acrosome assembly |
GO_0007289 | Biological process | spermatid nucleus differentiation |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005829 | Cellular component | cytosol |
GO_0005643 | Cellular component | nuclear pore |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005737 | Cellular component | cytoplasm |
GO_0003677 | Molecular function | DNA binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | AGFG1 |
Protein name | Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein) ArfGAP with FG repeats 1 isoform 4 ArfGAP with FG repeats 1 ArfGAP with FG repeats 1 isoform 3 ArfGAP with FG repeats 1 isoform 2 ArfGAP with FG repeats 1 isoform 1 |
Synonyms | RAB RIP HRB |
Description | FUNCTION: Required for vesicle docking or fusion during acrosome biogenesis (By similarity). May play a role in RNA trafficking or localization. In case of infection by HIV-1, acts as a cofactor for viral Rev and promotes movement of Rev-responsive element-containing RNAs from the nuclear periphery to the cytoplasm. This step is essential for HIV-1 replication. . |
Accessions | ENST00000310078.13 [P52594-1] C9J2I0 A0A0S2Z3Z1 ENST00000456594.1 ENST00000458212.1 P52594 ENST00000373671.7 [P52594-2] H7C0S7 A0A0S2Z444 ENST00000409315.5 ENST00000409979.6 [P52594-4] ENST00000409171.5 [P52594-3] B8ZZY2 A0A0S2Z462 A0A0S2Z3Y3 |